Value of Computer Software for Assisting Sonographers in the Diagnosis of Thyroid Imaging Reporting and Data System Grade 3 and 4 Thyroid Space‐Occupying Lesions

Abstract

Objectives-To analyze the ability of thyroid ultrasound computer-aided diagnosis (CAD) detection software (AmCAD-UT; AmCAD BioMed Corporation, Taipei, Taiwan) to assist sonographers in diagnosing Thyroid Imaging Reporting and Data System grade 3 and 4 space-occupying lesions and to provide evidence for ultrasound doctors (UDs) to use the diagnostic recommendations of the AmCAD system to inform clinical decisions.Methods-In group 1, a retrospective study was performed on 234 cases of thyroid lesions confirmed by surgical pathology. The sensitivities, specificities, and accuracies of the diagnoses determined by the same UD independent of the software (UD) and after consulting the CAD software (UD + CAD) and by the software alone (CAD) were compared. In group 2, a prospective study was performed on 220 individuals with thyroid space-occupying lesions recommended by physicians from our hospital to undergo needle biopsy to confirm the diagnosis. Ultrasound images were imported into AmCAD, and recommendations for needle biopsy or periodic follow-up were obtained. According to the pathologic results of needle biopsy, consistency and coincidence rates of diagnostic recommendations for AmCAD were obtained.Results-In group 1, CAD and UD + CAD diagnoses achieved significantly higher sensitivities and accuracies of diagnosis than did independent diagnosis by the UD (P < .05). In group 2, the software showed an overall intraclass correlation (κ = 0.786) and a diagnosis coincidence rate of 93.6% with needle biopsy results.Conclusions-AmCAD-UT Detection improved the ability of UDs to diagnose Thyroid Imaging Reporting and Data System grade 3 and 4 space-occupying lesions. Diagnostic recommendations of AmCAD are relatively consistent with needle biopsy results and can reduce the rate of unnecessary diagnostic needle biopsies.

Differential diagnosis and feature visualization for thyroid nodules using computer-aided ultrasonic diagnosis system: initial clinical assessment

“…AmCAD-UT, a Food and Drug Administration (FDA)-approved CAD software device, is utilized to not only differentiate benign and malignant nodules, but also diagnose the features of thyroid nodules with different thyroid imaging reporting and data system (TI-RADS) [15]. Previous studies have shown that AmCAD-UT system has comparable performance to physicians in terms of diagnostic efficiency [13,[15][16][17]. However, there are few no detailed reports focused on diagnostic efficacy of nodule size using AmCAD-UT system.…”

Diagnostic value of a dynamic artificial intelligence ultrasonic intelligent auxiliary diagnosis system for benign and malignant thyroid nodules in patients with Hashimoto thyroiditis

“…The system of AI ultrasonic intelligent auxiliary diagnosis, on the foundation of the static ultrasonic images, could quickly and conveniently automatically recognize and outline nodules and discriminate between benign and malignant nodules (13)(14)(15). Lu et al (23) retrospectively studied 234 thyroid nodules that had been confirmed by surgery and pathology. In their study, the AmCAD-UT system was used to analyze preoperative ultrasound images of nodules and was found to have a diagnostic sensitivity, specificity, and accuracy of 89.0%, 82.5%, and 86.8%, respectively.…”

Advancements in AI-driven diagnostic radiology: Enhancing accuracy and efficiency

“…Due to the high diagnostic accuracy of this model, only 26% of the population (level 4) required additional biomarker testing. Similar to this, a commercially available AI tool has prospectively proved its capacity to assess malignancy risk in thyroid lesion assessment using ultrasonography, preventing needless biopsies (level 4) (47).…”